Council Of EU Supports Urgent MDR Action By European Commission
Executive Summary
At last! After an intense year of lobbying by the medtech sector decision-makers have agreed to crisis management action for the EU’s Medical Device Regulation.
You may also be interested in...
German Medtechs Say MDR Ball Is In EU’s Court, Plus DRG Changes and ESG Reactions
Marc-Pierre Möll, CEO of German medtech-industry association BVMed, is hoping for a more collaborative year in 2023 after the health ministry came out with proposals to change the DRGs system and the EU finally conceded that its unhelpful MDR timetable was riding roughshod over the wellbeing of patients.
How Legacy Devices Can Remain On Market Once Former Certificates Have Expired
Published immediately after the 9 December meeting on the MDR at the Council of the EU, a new position paper explains a way forward for devices whose former MDD and AIMDD certificates are due to expire ahead of certification under the MDR.
UK Govt Under Fire From Pharma Industry Over Statutory Pricing Scheme Changes
The UK’s pharmaceutical industry association, the ABPI, claims that “fundamental failures” in the government’s consultation and impact assessment for proposed changes to the branded medicines statutory pricing scheme could be grounds for legal challenge.